Synergistic combinations of OX40L antibodies for the treatment of GVHD
US9512229B2 · kind B2 · utility
8Cited by
13References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2016 |
| Grant date | Dec 6, 2016 |
| Priority date | — |
| Expiry date | Apr 29, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.